跳至主要内容
临床试验/NCT04208815
NCT04208815已完成不适用

Evaluation of Dietary Milk Polar Lipids on Serum Cholesterol and Gut Microbiota in Healthy Adults

University of Connecticut2 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2020年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
35
试验地点
2
主要终点
Change from Baseline Serum Total Cholesterol at 4 weeks

研究概览

简要总结

The purpose of this study is to examine whether the daily consumption of 5 g of milk polar lipids influences serum lipids and gut microbiota composition in healthy adults.

详细描述

Healthy adults will be recruited to participate in a randomized, single-blind, controlled, 13-week crossover trial. Participants will follow a 2-week run-in control period consuming their habitual diets. Participants will then be randomized to consume 20 g of milk fat daily in the form of either a reconstituted milk polar lipid (MPL)-rich dairy beverage (MPL; providing 5.3 g MPL daily) or a control dairy beverage (CTL; providing 0.3 g MPL daily), each for 4- weeks, separated by a 3-week washout period. Participants will be instructed to consume intervention treatment/control beverages at breakfast (50 g) and dinner (50 g) and reconstitute the powders in water immediately prior to consumption. With the exception of the intervention beverages, participants will be asked to maintain their normal diet and exercise habits throughout the study. Venous blood will be collected after a 12-hour overnight fast into EDTA-coated (glucose analysis) and serum (lipid analyses) collection tubes. Passive drool and stool samples will be collected at the end of the run-in period (baseline) and intervention periods (treatment and control). Participants will be asked to complete a 5-day dietary record, food preference/liking/sedentary behavior surveys, and 7-day physical activity diary at the beginning and end of intervention periods.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 18 to 50 years
  • Body Mass Index < 30 kg/m^2
  • Willing to consume experimental intervention products on a daily basis

排除标准

  • Outside of age range (<18 or >50 years old)
  • Body Mass Index > 30 kg/m^2
  • Triglycerides are higher than 500 mg/dL, glucose levels higher than 126 mg/dL, or total cholesterol higher than 240 mg/dL
  • Self-reported history of renal or liver disease, diabetes, thyroid disease, gallbladder disease, eating disorders, heart disease, stroke, cancer and gut-associated pathologies
  • Weight loss greater than 10% of body weight over preceding 4 weeks
  • Taking probiotic supplements or oral antibiotics up to 1 month prior to the study and during the study
  • Allergy to dairy or lactose intolerance
  • Taking lipid-lowering medications

结局指标

主要结局

Change from Baseline Serum Total Cholesterol at 4 weeks

时间窗: 4 weeks

Measurement of serum cholesterol (mg/dL) at the beginning and end of each 4-week intervention arms.

次要结局

  • Change in Fecal Microbiota Shannon Index at 4 weeks(4 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Christopher Blesso

Associate Professor

University of Connecticut

研究点 (2)

Loading locations...

相似试验